The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-10-01
著者
-
Shaughnessy John
Donna D. And Donald M. Lambert Laboratory Of Myeloma Genetics Myeloma Institute For Research And The
-
Johnson Sarah
Department Of Cellular Pathology The Newcastle Upon Tyne Nhs University Hospital Foundation Trust
-
Barlogie Bart
Myeloma And Transplantation Research Center University Of Arkansas For Medical Sciences
-
Johnson Sarah
Department Of Pathology University Of Arkansas For Medical Sciences
-
Albino Anthony
Signal Genetics Llc
-
HEUCK Christoph
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
QU Pingping
Cancer Research and Biostatistics
-
ZHANG Qing
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
Heuck Christoph
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Barlogie Bart
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Zhang Qing
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Shaughnessy John
Donna D And Donald M Lambert Laboratory For Myeloma Genetics University Of Arkansas For Medical Sciences
関連論文
- Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury
- Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma
- Global Gene Expression Profiling in the Study of Multiple Myeloma
- THE ARKANSAS APPROACH TO THE TREATMENT OF MULTIPLE MYELOMA
- The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma